Michael Anthony Diaz

Michael Diaz practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Michael Diaz's NPI, 1811485816, was assigned on April 25, 2018. Michael Diaz graduated from University of California (San Francisco) School of Medicine in 2018. Michael Diaz's California license number on file is A167003.

Michael Diaz's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Michael Diaz's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Michael Diaz is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Michael Diaz to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Diaz practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Michael Diaz's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Michael Diaz is board certified in neurology by the American Board of Psychiatry and Neurology. Michael Diaz has a license on file in California.

Dmand AI lists acute mini-stroke (TIA) and stroke among the conditions Michael Diaz treats.

CMS data shows 101 Medicare services from Michael Diaz across 2 procedure codes in 2024, for 50 Medicare patients. Medicare paid $16,536 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Michael Diaz in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 68% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Diaz's median patient age at 70, with 50% women.

In 2024, Michael Diaz wrote 28 Medicare Part D claims. 79% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $382 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Michael Diaz for performance year 2024, reported as part of a group. Michael Diaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Michael Diaz, published from 2014 to 2023. Michael Diaz's most frequent co-authors are Nicole Lyn Rosendale, MD and David Spiegel, MD.

CMS Open Payments shows 2 general payments to Michael Diaz from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Ceribell, Inc. paid the most, $140.

Michael Diaz graduated from University of California (San Francisco) School of Medicine in 2018. Michael Diaz is a member of AAN and Neurocritical Care Society.

Michael Diaz is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.